Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses.
Samuel BitounJérôme AvouacJulien HenryRoba GhossanOmar Al TabaaRakiba BelkhirGaetane NocturneAlice Andrée MariaggiFlore RozenbergChristelle Vauloup-FellousXavier MarietteRaphaèle SerorPublished in: RMD open (2022)